600488.SH
津药药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 5.17
−6.17%Margins
Gross margin
41.2%
EBITDA margin
17.8%
EBIT margin
4.8%
Net margin
1.0%
FCF margin
3.1%
0.9%
Return on equity
0.5%
Return on assets
3.6%
Return on invested capital
0.48x
Asset turnover
CNY 135.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026